Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosome production factor 2 homolog (RPF2) is a nucleolar protein essential for the assembly and maturation of the large ribosomal subunit, particularly through its involvement in the incorporation of the 5S ribonucleoprotein particle into ribosome precursors[5][2]. It binds 5S rRNA and plays a regulatory role in ribosome biogenesis, impacting cellular processes such as localization to the nucleolus and regulation of signal transduction by p53 class mediator[2][4][5]. In cancer, especially colorectal cancer, RPF2 expression has been implicated in mediating chemoresistance, potentially through upregulation of ABC transporter proteins by modulating signaling pathways including CARM1 and MYCN[1]. No direct pharmacological modulators or clinical biomarkers are currently described for this protein, and it is not classically classified as a therapeutic target, but its emerging role in cancer mechanisms makes it of increasing biological interest[1][2][5].
Not applicable (no known drugs that specifically target RPF2)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosome production factor 2 homolog (RPF2).